Biotest GmbH & Co. KGaA (HAM:BIO0)
32.20
-0.10 (-0.31%)
At close: Jun 10, 2026
Biotest GmbH & Co. KGaA Revenue
Biotest GmbH & Co. KGaA had revenue of 124.20M EUR in the quarter ending March 31, 2025, a decrease of -42.29%. This brings the company's revenue in the last twelve months to 635.20M, down -18.83% year-over-year. In the year 2024, Biotest GmbH & Co. KGaA had annual revenue of 726.20M with 6.08% growth.
Revenue (ttm)
635.20M
Revenue Growth
-18.83%
P/S Ratio
2.01
Revenue / Employee
254.59K
Employees
2,495
Market Cap
1.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 726.20M | 41.60M | 6.08% |
| Dec 31, 2023 | 684.60M | 168.50M | 32.65% |
| Dec 31, 2022 | 516.10M | 500.00K | 0.10% |
| Dec 31, 2021 | 515.60M | 31.40M | 6.48% |
| Dec 31, 2020 | 484.20M | 65.10M | 15.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Darwin AG | 54.30M |
| Paion AG | 14.81M |
| 2invest AG | 8.89M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 57.01K |
| co.don AG | 22.00K |
| bioXXmed AG | 20.49K |